department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

TRAVATAN Z · pharmadog

pharmadog
drugs
TRAVATAN Z

drug

patient view →

TRAVATAN Z

updated 2mo ago

by Sandoz Inc

community read0 votes

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

brand

TRAVATAN Z

generic

TRAVOPROST

Data sources

ClinicalTrials.gov

last refreshed 1h ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

🐶 often sniffed alongside

top 5

tagApproval36 co-mentions · 11 sources
drugtravoprost ER35 co-mentions · 11 sources
drugiLution travoprost35 co-mentions · 11 sources
drugIDOSE TR35 co-mentions · 11 sources
drugTRAVOPROST18 co-mentions · 11 sources

Trials studying TRAVATAN Z

phase4Travoprost Intraocular Implant + iStent Infiniterecruitingn=150
phase3Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implantrecruitingn=510
phase3Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implantrecruitingn=610
—Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcgrecruitingn=30
phase4Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery Alonerecruitingn=132
phase4Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle Glaucomarecruitingn=20
phase2A Study to Evaluate the Efficacy and Safety of OTX-TIC (Travoprost) Intracameral Implant for Patients With Open-angle Glaucoma (OAG) or Ocular Hypertension (OHT)completedn=83
phase3Randomized Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5%completedn=590

more trials →